JP2004535161A5 - - Google Patents

Info

Publication number

JP2004535161A5

JP2004535161A5 JP2002571825A JP2002571825A JP2004535161A5 JP 2004535161 A5 JP2004535161 A5 JP 2004535161A5 JP 2002571825 A JP2002571825 A JP 2002571825A JP 2002571825 A JP2002571825 A JP 2002571825A JP 2004535161 A5 JP2004535161 A5 JP 2004535161A5

Authority

JP

Japan

Prior art keywords

polypeptide

seq

nucleic acid

amino acid

antibody

Prior art date

2002-03-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 41
• 102000004196 processed proteins & peptides Human genes 0.000 claims 41
• 108090000765 processed proteins & peptides Proteins 0.000 claims 41
• 102000039446 nucleic acids Human genes 0.000 claims 13
• 108020004707 nucleic acids Proteins 0.000 claims 13
• 150000007523 nucleic acids Chemical class 0.000 claims 13
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 12
• 125000003275 alpha amino acid group Chemical group 0.000 claims 11
• 150000001413 amino acids Chemical class 0.000 claims 11
• 239000008194 pharmaceutical composition Substances 0.000 claims 9
• 150000001875 compounds Chemical class 0.000 claims 8
• 238000000034 method Methods 0.000 claims 7
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 6
• 230000002401 inhibitory effect Effects 0.000 claims 5
• 239000002773 nucleotide Substances 0.000 claims 5
• 125000003729 nucleotide group Chemical group 0.000 claims 5
• 108091005804 Peptidases Proteins 0.000 claims 4
• 239000004365 Protease Substances 0.000 claims 4
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 4
• 230000027455 binding Effects 0.000 claims 4
• 230000000694 effects Effects 0.000 claims 4
• 239000005557 antagonist Substances 0.000 claims 3
• 230000000295 complement effect Effects 0.000 claims 3
• 238000005406 washing Methods 0.000 claims 3
• 102000008847 Serpin Human genes 0.000 claims 2
• 108050000761 Serpin Proteins 0.000 claims 2
• 239000000556 agonist Substances 0.000 claims 2
• 239000003001 serine protease inhibitor Substances 0.000 claims 2
• 230000000890 antigenic effect Effects 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 239000013604 expression vector Substances 0.000 claims 1
• 239000012634 fragment Substances 0.000 claims 1
• 238000009396 hybridization Methods 0.000 claims 1
• 230000001939 inductive effect Effects 0.000 claims 1
• 239000003112 inhibitor Substances 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 230000001404 mediated effect Effects 0.000 claims 1
• 239000000758 substrate Substances 0.000 claims 1
• 230000002194 synthesizing effect Effects 0.000 claims 1